Estimating the risk after gestational diabetes mellitus: Can we improve the information from the postpartum OGTT?

American Journal of Physiology - Endocrinology and Metabolism

Volumn 304, Issue 5, 2013, Pages

  Göbl, Christian S ^a,b   Bozkurt, Latife ^b   Prikoszovich, Thomas ^b   Tura, Andrea ^c   Pacini, Giovanni ^c   Kautzky Willer, Alexandra ^b  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c CNR   (Italy)

Author keywords

Gestational diabetes mellitus; Oral glucose tolerance test; Postpartum risk stratification

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BODY COMPOSITION; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INFLAMMATION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUERPERIUM;

ADULT; ATHEROSCLEROSIS; BLOOD GLUCOSE; BODY COMPOSITION; CELL ADHESION MOLECULES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; KAPLAN-MEIER ESTIMATE; LIPIDS; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT;

EID: 84874536207     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00461.2012     Document Type: Article

References (39)

1. Abdul-Ghani MA, Jenkinson CP, Richardson D, Tripathy D, De-Fronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55: 1430-1435, 2006.
2. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29: 1130113-9, 2006.
3. Abdul-Ghani MA, Abdul-Ghani T, Ali N, DeFronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31: 1650-1655, 2008.
4. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia study. Diabetes Care 32: 281-289, 2009.
5. Abdul-Ghani MA, DeFronzo RA. Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 32: S194-S198, 2009.
6. American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care 35: S11-S63, 2012.
7. Baldassare D, DeJong A, Amato M, Werba JP, Castelnuovo S, Frigerio B, Vegla F, Tremoli E, Sirtori CR. Carotid intima-media thickness and markers of inflammation, endothelial damage and hemostasis. Ann Med 40: 21-44, 2008.
8. Blüher M, Unger R, Rassoul F, Richter V, Paschke R. Relation between glycemic control, hyperinsulinaemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or Type II diabetes. Diabetologia 45: 210-216, 2002.
9. Bozkurt L, Göbl CS, Tura A, Chmelik M, Prikoszovich T, Kosi L. Fatty Liver Index predicts further methabolic deteriorations in women with previous gestational diabetes. Plos One 7: e32710, 2012.
10. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 115: 483-491, 2005.
11. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204: 479-487, 2011.
12. Expert Committee on the Diagnosis, and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197, 1997.
13. Genuth S, Alberti KG, Bennett P. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167, 2003.
14. Göbl CS, Bozkurt L, Prikoszovich T, Winzer C, Pacini G, Kautzky-Willer A. Early possible risk factors for overt diabetes after gestational diabetes mellitus. Obstet Gynecol 118: 71-78, 2011.
15. Goeman JJ. L1 penalized estimation in the Cox proportional hazards model. Biom J 52: 70-84, 2010.
16. Heitritter SM, Solomon CG, Michell GF, Skali-Ounis N, Seely EW. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes. J Clin Endocrinol Metab 90: 3983-3988, 2005.
17. International Association of Diabetes, and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33: 676-682, 2010.
18. Iwaki T, Urano T, Umemura K. PAI-1, progress in understanding the clinical problem and its aetiology. Brit J Haemat 157: 291-298, 2012.
19. Kahn SE, Prigeon RL, McCulloch DSK. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42: 1663-1672, 2002.
20. Kautzky-Willer A, Krssak M, Winzer C, Pacini G, Tura A, Farhan S. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52: 244-251, 2003.
21. Kautzky-Willer A, Handisurya A. Metabolic diseases and associated complications: sex and gender matter! Eur J Clin Invest 39: 631-648, 2009.
22. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care 25: 1862-1868, 2002.
23. Kjos Sl Buchanan TA. Gestational diabetes mellitus. N Engl J Med 341: 1749-1756, 1999.
24. Kwong S, Mitchell RS, Senior PA, Chik CL. Postpartum Diabetes Screening. Diabetes Care 32: 2242-2244, 2009.
25. Luijf YM, Hermanides J, Serlie MJ, Hoekstra JB, Soerters MR. The added value of oral glucose tolerance testing in pre-diabetes. Curr Diab Rev 7: 56-60, 2011.
26. Manco M, Panuzi S, Macfarlane DP, Golay A, Melander O, Konrad T. Insulin Sensitivity and Cardiovascular Risk Consortium (RISC). Onehour plasma glucose identifies insulin resistance and β-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study. Diabetes Care 33: 2090-2097, 2010.
27. Metzger BE, Coustan DR. The organizing committee. Summary and recommendations of the Fourth International Workshop-Conference on gestational diabetes mellitus. Diabetes Care 21: B161-B167, 1998.
28. Meyer C, Pimenta W, Woerle HJ, Van Haeften T, Szoke E, Mitrakou A, Gerich J. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29: 1909-1914, 2006.
29. Pacini G, Tonolo G, Sambataro M, Maioli M, Ciccarese M, Brocco E, Avogaro A, Nosadini R. Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol Endocrinol Metab 274: E592-E599, 1998.
30. Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrin Metab 93: 4774-4779, 2008.
31. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2011. ISBN 3-900051-07-0, http://www.R-project.org/(19.11.2011).
32. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancy. Nutr Metab Cardiovasc Dis 21: 706-712, 2011.
33. Strandberg TE, Pienimäki T, Strandberg AY, Salomaa VV, Pitkälä KH, Tilvis RS, Miettinen TA. One-hour glucose, mortality, and risk of diabetes: a 44-year prospective study in men. Arch Intern Med 171: 941-942, 2011.
34. Tura A, Morbiducci U, Sbrignadello S, Winhofer Y, Pacini G, Kautzky-Willer A. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance? AM J Physiol Regul Integr Comp Physiol 300: R941-R948, 2011.
35. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabetes Med 19: 708-723, 2002.
36. Wasada T, Kuroki H, Katsumori K, Arii H, Sato A, Aoki K, Jimba S, Hanai G. Who are more insulin resistant, people with IFG or people with IGT? Diabetologia 47: 758-759, 2004.
37. Weyer C, Bogardus C, Pratley RE. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48: 2197-2203, 1999.
38. Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27: 1721-1727, 2004.
39. Zhou W, Gu Y, Li H, Lou M. Assessing 1-h plasma glucose and shape of glucose curve during oral glucose tolerance test. Eur J Endocrin 155: 191-197, 2006.